MedPath

Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial

Not Applicable
Conditions
Percutaneous Coronary Intervention
Registration Number
NCT02269449
Lead Sponsor
NPO International TRI Network
Brief Summary

The objectives of this study are to demonstrate the safety and efficacy of the new 6Fr sheath (Glidesheath slender; Terumo, Tokyo,Japan ; GSS) compared with the contemporary 5Fr sheath (Hydrophilic coating sheath from Terumo; Tokyo, Japan (standard of care ; SOC).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1900
Inclusion Criteria
  • Patient is able to verbally acknowledge an understanding of the associated risks, benefits and treatment alternatives and he or his legally authorized representative provides written informed consent prior to the randomization, as approved by the appropriate IRB.
  • Patient who is expected to diagnose by coronary artery angiography or followed by PCI.
  • Patient must agree to undergo all protocol-required follow-up examinations.
  • Patient who can accept radial access.
Exclusion Criteria
  • Patient has other medical illness (e.g., cancer or congestive heart failure) that may cause non-compliance with the protocol, confound the data interpretation or is associated with a limited life expectancy (i.e., less than one year).
  • Hemodialysis patient
  • STEMI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Radial artery occlusionDay 1
Local bleeding from puncture siteDay 1
Secondary Outcome Measures
NameTimeMethod
Vascular access site complicationDay 1
Procedure success rateDay 1
Radial spasm during the index procedureDay 1
Total Procedure TimeDay 1
Pain scoreDay 1
Total Radiation DosesDay 1
Device failure for the assigned sheath introducerDay 1
Total Amount of Contrast DyeDay 1

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.